https://www.selleckchem.com/pr....oducts/zinc05007751.
Median follow-up was 67.2months (50.2 MIH, 79.3 OAH; range 11.1-131.2) and there was no difference in remission (81.8% MIH vs 76.5% OAH; p=.68). There were 7 recurrences (4 MIH, 3 OAH) and 3 deaths (2 MIH, 1 OAH). Overall survival was 97.3% at 2years and 88.5% at 5years. There was no significant difference in 5-year survival by mode of surgery (MIH 90.9%, OAH 83.3%; p=.4. Patients undergoing MIH at our centers have similar oncologic outcomes, lower surgical blood loss and shorter hospital stay compared to those undergoing OAH. Ov
Like
Comment
Share
